| Category |
Drug |
Trade
Name |
Company |
Price
(2002) |
| NNRTI |
efavirenz |
Sustiva |
Merck & Co., Inc. |
US$ 500/year
US$ 1.37/day)
|
| NNRTI |
nevirapine |
Viramune |
|
US$ 438/year (US$ 1.20/day)
|
| NNRTI |
delavirdine |
Rescriptor |
|
|
| NRTI |
zidovudine + lamivudine |
Combivir (GSK) |
|
|
| NRTI |
lamivudine |
Epivir |
|
US$ 234/year
(US$ 0.64/day)
|
| NRTI |
abacavir |
Ziagen |
GlaxoSmithKline |
US$ 1387/year
US$ 3.80/day)
|
| NRTI |
zidovudine |
Retrovir |
GlaxoSmithKline |
US$ 584/year
US$ 1.60/day)
|
| NRTI |
stavudine |
Zerit |
|
US$ 55/year US$ 0.15/day)
based on an average daily dose
of 80mg Lower capsule dosages priced inline with this
offer.
|
| NRTI |
zalcitabine |
Hivid |
Roche |
Cost per pack of 100 tablets is US$ 14.70 (CHF 25.00)
US$ 161/year (daily treatment
cost of US$ 0.44/day)
|
| NRTI |
didanosine |
Videx |
Bristol-Myers
Squibb Co. |
US$ 310/year (US$ 0.85/day –
average daily dose of 400mg)
Lower tablet dosages prices in
line with this offer
|
| NRTI |
ZDV + 3TC + NVP |
|
|
|
| NRTI |
ABC + 3TC + NVP |
Trizivir (GSK) |
GlaxoSmithKline |
US$ 2409/year
US$ 6.60/day)
|
| NRTI |
3TC +d4T (40mg) |
|
|
|
| NRTI |
3TC +d4T (30mg) |
|
|
|
| PI |
nelfinavir |
Viracept |
Roche |
Bottle of 270 tablets: US$ 200.00
(CHF 340.00)
US$ 2704/year (US$ 7.41/day) for 1250mg twice daily regimen
|
| PI |
ritonavir |
Norvir |
|
“Booster dose”:
US$ 83/year (US$
0.23/day)
|
| PI |
amprenavir |
Agenerase |
GlaxoSmithKline |
|
| PI |
saquinavir |
Fortovase also called: soft-gel cap |
Roche |
Bottle of 180 capsules: US$ 66.18 (CHF 112.50)
US$ 1342/year (US$ 3.68/day)
for daily dose 1000mg twice
daily to be boostered with ritonavir
100mg twice daily
|
| PI |
saquinavir |
Invirase also called: hard-gel cap |
Roche |
Bottle of 180 capsules: US$ 66.18 (CHF 112.50)
US$ 1342/year (US$ 3.68/day)
for daily dose 1000mg twice
daily to be boostered with ritonavir
100mg twice daily
|
| PI |
lopinavir + ritonavir |
Kaletra (GSK) |
|
|
| PI |
indinavir |
Crixivan |
Merck & Co., Inc. |
US$ 600/year
(US$ 1.64/day)
|
